SCHEMBL20192209

SCHEMBL20192209

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C[C@H](C)C(=O)NOCc1ccc(NC(=O)[C@@H](CCCNC(N)=O)NC(=O)C(NC(=O)CCCC(=O)N2CCC(C(=O)O)CC2)C(C)C)cc1)OC)N(C)C(=O)[C@@H](NC(=O)C(C(C)C)N(C)C)C(C)C

nearest known ligand 0.50

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.50
FOLH1 Q04609 3/20 0.47
TTR P02766 2/20 0.44
FAP Q12884 5/20 0.40
SSTR2 P30874 2/20 0.37
NECTIN4 Q96NY8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17575283 1.00 CYP3A4 (0.50) CYP3A4FOLH1TTRFAPSSTR2
SCHEMBL17575423 0.95 CYP3A4 (0.53) CYP3A4FOLH1TTRFAPSSTR2
SCHEMBL16730856 0.95 CYP3A4 (0.55) CYP3A4FOLH1TTRFAPSSTR2
SCHEMBL19522554 0.95 CYP3A4 (0.55) CYP3A4FOLH1TTRFAPSSTR2
SCHEMBL20192266 0.94 CYP3A4 (0.51) CYP3A4FOLH1TTRFAPSSTR2
SCHEMBL17575259 0.92 CYP3A4 (0.50) CYP3A4FOLH1TTRFAPSSTR2
SCHEMBL20192098 0.92 CYP3A4 (0.50) CYP3A4FOLH1TTRFAPSSTR2
SCHEMBL20192258 0.92 CYP3A4 (0.48) CYP3A4FOLH1TTRFAPSSTR2
SCHEMBL17575384 0.92 CYP3A4 (0.48) CYP3A4FOLH1TTRFAPSSTR2
SCHEMBL19084307 0.91 CYP3A4 (0.49) CYP3A4FOLH1TTRFAPSSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9981046-B2 Drug-conjugates, conjugation methods, and uses thereof Concortis Biosystems, Corp., a wholly owned Subsidiary of Sorrento Therapeutics, Inc. (US) 2018-05-29 US disclosed